advertisement
Home » News » Old Drug May Help Reduce Mania

Old Drug May Help Reduce Mania

pillsA new provocative study suggests the off-label use of a drug known to treat breast cancer may provide benefit to bipolar patients suffering from mania.

Animal studies and human pilot trials have suggested that tamoxifen may be effective in treating mania—an abnormally elevated mood that features impulsive behavior, higher energy and activity levels, and disconnected thoughts—in patients with bipolar disorder.

In a small, three-week trial of tamoxifen, Ayşegül Yildiz, M.D., of the Dokuz Eylül University Medical School, Izmir, Turkey, and colleagues conducted a clinical trial with 66 patients age 18 to 60, all of whom were diagnosed with bipolar disorder and were currently in a manic state or a mixed state that included mania.

Participants were randomly assigned to take tamoxifen (40 milligrams to 80 milligrams per day) or identical placebo tablets twice daily for up to three weeks. Participants in both groups also were given up to 5 milligrams per day of the sedative lorazepam as needed to control their symptoms.

Tamoxifen interferes with the effects of the hormone estrogen, which accounts for its effects against breast cancer, according to background information in the article. However, tamoxifen also inhibits the actions of a family of enzymes known as protein kinase C.

Abnormal levels of activity by these enzymes have been associated with bipolar disorder and related dysfunctions, such as distractibility, impaired judgments and disorganized thoughts.

A total of 50 patients—29 assigned to take tamoxifen and 21 assigned to take placebo—completed the 21-day trial. Patients in the tamoxifen group had significantly lower scores on tests used to measure the severity of mania at the end of the three-week period, while those in the placebo group had scores that slightly increased.

Almost half (48 percent) of patients taking tamoxifen responded to the drug—defined as a reduction of at least half in mania scores—compared with 5 percent of those taking placebo, and 28 percent vs. zero achieved cutoff scores for mania remission.

Patients taking tamoxifen also used less lorazepam during the study—an average of 25.2 milligrams compared with 41.8 milligrams for patients in the placebo group. “Moreover, all subjects used less lorazepam as the trial progressed, and the rate of decrease was 2.5 times greater with tamoxifen,” the authors write. Both tamoxifen and placebo were well tolerated.

“The findings encourage further clarification of the role of protein kinase C in the pathophysiologic mechanism of bipolar 1 disorder and development of novel anti–protein kinase C agents as potential antimanic or mood-stabilizing agents,” the authors conclude.

The reports is found in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Source: American Medical Association

Old Drug May Help Reduce Mania

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2015). Old Drug May Help Reduce Mania. Psych Central. Retrieved on October 19, 2018, from https://psychcentral.com/news/2008/03/06/old-drug-may-help-reduce-mania/2012.html

 

Scientifically Reviewed
Last updated: 6 Oct 2015
Last reviewed: By John M. Grohol, Psy.D. on 6 Oct 2015
Published on PsychCentral.com. All rights reserved.